Pathogens | Seroprevalence rates for this study, % | Seroprevalence rates for comparative studies, % (description of population) |
---|---|---|
C. pneumoniae | 86 | 63 (Brooklyn, NY, USA) [32], 42 (Alaskan Natives) [31] |
H. pylori | 57 | 62 (Mexican American)* [62], 26 (non-Hispanic White)* [62] |
T. gondii | 9 | 25 (Mexican American)* [33], 24 (non-Hispanic White)* [33], 25 (general U.S. population)* [33] |
CMV | 55 | 85 (Mexican American)* [6], 57 (non-Hispanic White)* [6], 62 (general U.S. population)* [6] |
EBV | 46 | 73-90 (general U.S. adult population) [34] |
HSV-1 | 82 | 88 (Mexican American)* [6], 65 (non-Hispanic White)* [6], 68 (general U.S. population)* [6] |
HSV-2 | 22 (total) 25 (women) 16 (men) | 38 (Mexican American women)* [33], 27 (Mexican American men)* [33], 65 (non-Hispanic Black women)* [33], 43 (non-Hispanic Black men)* [33], 22 (non-Hispanic White women)* [33], 18 (non-Hispanic White men)* [33], 25 (general U.S. population)* [33] |
HHV-6 | 82 | 60-70 [63]; 66-94 [4] |
VZV | 92 | 97(Mexican American)* [64], 97 (non-Hispanic White)* [64], 96 (general U.S. population)* [64] |
Ad-36 | 13 | 11 (non-obese) [36], 30 (obese) [36] |
HAV | 73 | 82 (Mexican American)* [33], 29 (non-Hispanic White)* [33] |